+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Absorbable Tissue Spacer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 5119911
  • Report
  • January 2022
  • Region: Global
  • 110 Pages
  • Mordor Intelligence


  • BD (CR Bard)
  • Biocomposites
  • Bioprotect Ltd.
  • Boston Scientific
  • Palette Life Sciences

The Absorbable Tissue Spacer market studied is anticipated to grow with a CAGR of nearly 4.9%, during the forecast period. Certain factors that are driving the market growth include increasing prevalence of cancer and advantages associated with tissue spacer.

Globally, cancer is one of the leading causes of death. The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period. The World Health Organization (WHO) estimates the rate of cancer number to increase to 70% over the next two decades.

Additionally, the increased burden of several lifestyle disorders is also expected to drive the market, as biomarkers play a vital role in risk assessment, early diagnosis, and effective monitoring of treatment.

Key Market Trends

Hydrogel-based Spacers Hold Significant Share in the Global Absorbable Tissue Spacer Market

  • Hydrogel based tissue spacers have usage across many fields of cancer. Prostate-rectum hydrogel spacer application is a relatively safe technical procedure that is well tolerated and has a high technical success rate. Spacer application significantly reduces rectal radiation dose and results in long-term reductions in rectal toxicity, as well as improvements in bowel, urinary, and sexual quality of life.
  • Various recent clinical trial results have demonstrated that the prostate-rectum spacer application technique is safe and well tolerated, and that the space created significantly reduces rectal injury during radiation therapy, leading to long-term clinical benefits. A clinically significant reduction in radiation therapy complication rates leads to improved patient outcomes, reduced toxicity concerns, and hopefully overall cost reductions.

North America Dominates the Global Absorbable Tissue Spacer Market

As per the American Cancer Society, in 2018, the United States witnessed around 164,690 new cases of prostate cancer, causing over 26,430 deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. In order to tackle such challenges, extensive research in the field of diagnostics has been undertaken.

The ease in the US government regulations and availability of funds from various organizations, like the National Institute of Health, has provided the potential for researchers to invest more in developing absorbable tissue spacers. Hence, owing to the aforementioned factors, the entire region is expected to hold the major share in the global absorbable tissue spacer market.

Competitive Landscape

The global Absorbable Tissue Spacer market is competitive and consists of a few major players. Companies like Biocomposites, Bioprotect Ltd., Boston Scientific, CR Bard, Palette Life Sciences., among others, hold a substantial market share in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • BD (CR Bard)
  • Biocomposites
  • Bioprotect Ltd.
  • Boston Scientific
  • Palette Life Sciences

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Cancer
4.2.2 Advantages associated with Tissue Spacer
4.3 Market Restraints
4.3.1 High Cost and Lack of Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product Type
5.1.1 Hydrogel Based Spacers
5.1.2 Biodegradable Balloon Spacers
5.2 By Application
5.2.1 Radiotherapy
5.2.2 Infection Management
5.3 By End-User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Biocomposites
6.1.2 Bioprotect Ltd.
6.1.3 Boston Scientific
6.1.4 BD (CR Bard)
6.1.5 Palette Life Sciences
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Biocomposites
  • Bioprotect Ltd.
  • Boston Scientific
  • BD (CR Bard)
  • Palette Life Sciences
Note: Product cover images may vary from those shown